Device Trial Radar · NCT05870488
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction
Last checked: Nov 20, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
110
Planned (sponsor's estimate)
Start
May 23, 2023
Primary completion
Apr 23, 2025
Study completion Nov 2027
Sponsor
- Lead sponsor
- SI-BONE, Inc.Public (SIBN)
- Sponsor type
- Industry
- First posted
- May 23, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction (STACI) is a prospective, multicenter, study of SIJ fusion using the iFuse TORQ implant system.
Conditions
- Sacroiliac Joint Dysfunction
- Sacroiliac; Fusion
- Sacroiliac Disorder
- Sacroiliac Joint Pain
Interventions
Use of iFuse TORQDevice
Use of iFuse TORQ for the treatment of SI Joint dysfunction
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in SI joint pain measured by numerical rating scale (NRS)Time frame: At baseline and 6 months
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Napa Valley Orthopaedics
Napa, California
Source Healthcare
Santa Monica, California
Comprehensive Pain and Spine Specialists
Shelbyville, Indiana
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.